Beta Bionics Inc. Share Price

NASDAQ: BBNX

Mega Cap

$23.07

-0.21

(-0.92%)

as on September 18, 2025 at 1:29 am IST

$₹

Beta Bionics Inc. Stock Performance

as on September 18, 2025 at 1:29 am IST

Day's Low
Day's High
$22.91
Day's Price Range
$23.93
$23.07
0.69%
Downside
3.73%
Upside
52 Week's Low
52 Week's High
$8.89
52-Week Price Range
$26.66
$23.07
61.47%
Downside
15.56%
Upside

Beta Bionics Inc. share price movements today

Previous Close: $23.29
Open: $23.50
Volume: 578.9K
Day's Low - High: $22.91 - $23.93
52 Week Low - High: $8.89 - $26.66

Beta Bionics Inc. Historical Returns

1 Month Return: + 33.89 %
3 Month Return: + 29.98 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Beta Bionics Inc. Stock Fundamentals & Key Indicators

Check Beta Bionics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$945.1M

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

Return On Equity TTM

1053510600.00%

Beta Bionics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Beta Bionics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Beta Bionics Inc.	NA	$945.1M	NA	NA	-104.64%
Boston Scientific Corp.	BUY	$146.0B	155.98%	58.63	13.55%
Stryker Corporation	BUY	$144.1B	82.61%	49.98	12.25%
Abbott Laboratories	BUY	$233.5B	24.24%	16.83	32.43%
Medtronic Plc	BUY	$121.3B	-12.46%	26.13	13.63%

See all

Beta Bionics Inc. Stock's Interest Amongst Investors

Search interest for Beta Bionics Inc. Stock has decreased by -57% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:-57% versus previous 30 day period

Beta Bionics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	3	8	12	15	16	20	17	23
Gross Profit	1	5	7	8	8	11	8	12
Operating Income	-8	-8	-9	-11	-10	-13	-18	-19
EBITDA	-8	-8	-8	-13	-10	-17	-18	-19
Interest Expense	-	0	-	-	-	0	-	-
Depreciation	-	0	0	0	0	0	0	0
Income Before Tax	-8	-18	-12	-14	-9	-18	-28	-16
Income Tax Expense	-	-	-	-	-	-	-	-
Net Income	-8	-18	-12	-14	-9	-18	-28	-16
Net Profit Margin	-280.63%	-225.72%	-96.26%	-96.13%	-58.28%	-88.59%	-162.46%	-72.59%

Beta Bionics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	11	65
Gross Profit	0	6	35
Operating Income	-65	-35	-45
EBITDA	-63	-34	-44
Interest Expense	0	0	-
Depreciation	2	2	2
Income Before Tax	-64	-44	-54
Income Tax Expense	-	-	-
Net Income	-64	-44	-54
Net Profit Margin	-36173.74%	-367.64%	-84.08%

Beta Bionics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-18	-12	-14	-9	-18	-28	-16
Operating Cash Flow	-6	-12	-12	-9	-14	-19	-13
Investing Cash Flow	-69	7	3	15	-29	-179	6
Financing Cash Flow	0	0	0	-1	56	211	0
Change in Cash	26	-4	-9	17	12	12	-7

Beta Bionics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2023	Dec 2024
Net Income	-44	-54
Operating Cash Flow	-32	-48
Investing Cash Flow	-69	-3
Financing Cash Flow	101	55
Change in Cash	-1	3

Insights on Beta Bionics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NEGATIVE IMPACT
Price Dip
In the last 7 days, BBNX stock has moved down by -8.8%

About Beta Bionics Inc.

Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development and commercialization of various solutions to improve the health of insulin-requiring people with diabetes (PWD). The Company's product, the iLet Bionic Pancreas (iLet), is an insulin delivery device cleared by the United States Food and Drug Administration (FDA) to utilize adaptive closed-loop algorithms to autonomously determine every insulin dose without requiring a user to count carbohydrate intake. iLet is used for the treatment of Type 1 diabetes (T1D). The Company's solutions include iLet for Adults, iLet for Children, Bionic Circle App and iLet Simulator. The Company is in the early stages of developing an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing, commonly known in the diabetes industry as a patch pump. It is also in the early stages of developing a bihormonal configuration of the iLet.

Organisation	Beta Bionics Inc.
Headquarters	11 Hughes, Irvine, CA, United States, 92618
CEO	Mr. Sean T. Saint PE
E-voting on shares	Click here to vote

Key Management of Beta Bionics Inc.

Name	Title
Mr. Sean T. Saint PE	President, CEO & Director
Mr. Stephen H. Feider	CFO, Treasurer & Secretary
Mr. Mark Hopman M.B.A., R.Ph.	Chief Commercial Officer
Mr. David Henderson	Vice President of Operations
Blake Beber	Head of Investor Relations
Mr. Kevin Meinert	Vice President of Legal & Business Development
Dr. Steven Russell M.D., Ph.D.	Chief Medical Officer
Ms. Karen Hynes M.B.A.	Vice President of Marketing Execution
Mr. Mike Mensinger	Chief Product Officer

FAQs

What is Beta Bionics Inc. share price today?

Beta Bionics Inc. share price today is $23.07 as on September 18, 2025 at 1:29 am IST at the close of the market. Beta Bionics Inc. share today touched a day high of $23.93 and a low of $22.91.

What is the 52 week high and 52 week low for Beta Bionics Inc. share?

Beta Bionics Inc. share touched a 52 week high of $26.66 on September 15, 2025 and a 52 week low of $8.89 on April 7, 2025. Beta Bionics Inc. stock price today i.e. September 18, 2025 at 1:29 am IST is closed at $23.07,which is 13.47% down from its 52 week high and 159.51% up from its 52 week low.

What is Beta Bionics Inc.'s market capitalisation today?

Beta Bionics Inc. market capitalisation is $0.00T as on September 18, 2025 at 1:29 am IST.

How to invest in Beta Bionics Inc. Stock (BBNX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Beta Bionics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Beta Bionics Inc. Shares that will get you 0.0650 shares as per Beta Bionics Inc. share price of $23.07 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Beta Bionics Inc. Stock (BBNX) from India?

Indian investors can start investing in Beta Bionics Inc. (BBNX) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 4:39 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Beta Bionics Inc. stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 4:39 pm IST). Based on Beta Bionics Inc. share’s latest price of $23.07 as on September 18, 2025 at 1:29 am IST, you will get 0.4335 shares of Beta Bionics Inc.. Learn more about fractional shares .